REG - Indivior PLC - Transaction in Own Shares

IndiviorAnnouncement

28/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250128:nRSb8550Ua&default-theme=true

RNS Number : 8550U  Indivior PLC  28 January 2025

INDIVIOR PLC

SHARE REPURCHASE PROGRAM

WEEKLY REPORT

January 28, 2025

INDIVIOR PLC ("Indivior") announces that it purchased for cancellation a total
of 171,590 of its ordinary shares of $0.50 each through Morgan Stanley &
Co. International Plc in the period from January 20, 2025, up to and including
January 24, 2025, in connection with its $100m Share Repurchase Program.
Aggregated information on the purchase of these shares can be found in the
table below.

Following the purchase and cancellation of the above shares (including those
purchased but not yet settled), Indivior has 124,268,559 ordinary shares of
$0.50 each with voting rights in issue. There are no shares held in treasury.

The above figure (124,268,559) may be used by shareholders (and others with
notification obligations) as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or a change
to their interest in, Indivior under the FCA's Disclosure Guidance and
Transparency Rules.

All repurchases by Indivior are "On Exchange" transactions (as such term is
defined in the rules of the London Stock Exchange) and "on market" for the
purposes of the Companies Act 2006.

Aggregated information

 Trading Date  Trading Venue  Aggregated daily volume (number of shares)  Daily weighted average purchase price of the shares (p)
 20/01/2025    LSE            755                                         969.33
 20/01/2025    BATE           165                                         969.50
 20/01/2025    CHIX           3,732                                       975.22
 20/01/2025    AQUIS          1,042                                       974.66
 21/01/2025    LSE            16,701                                      996.66
 21/01/2025    BATE           5,413                                       996.24
 21/01/2025    CHIX           17,289                                      995.57
 21/01/2025    AQUIS          1,731                                       993.88
 22/01/2025    LSE            15,079                                      982.46
 22/01/2025    BATE           6,069                                       987.01
 22/01/2025    CHIX           17,050                                      980.52
 22/01/2025    AQUIS          2,634                                       976.16
 23/01/2025    LSE            17,154                                      956.56
 23/01/2025    BATE           5,674                                       955.01
 23/01/2025    CHIX           15,697                                      956.11
 23/01/2025    AQUIS          3,131                                       957.50
 24/01/2025    LSE            14,990                                      963.79
 24/01/2025    BATE           4,853                                       961.35
 24/01/2025    CHIX           19,737                                      964.99
 24/01/2025    AQUIS          2,694                                       961.30

 

 

Transaction details

In accordance with Article 5(1)(b) of the assimilated Market Abuse Regulation
(EU) No 596/2014, as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018 and Commission Delegated Regulation (EU)
2016/1052, a full breakdown of the individual purchases of ordinary shares
made by Morgan Stanley & Co. International Plc on behalf of Indivior
during the above period as part of the Share Repurchase Program can be found
at
www.indivior.com/en/investors/shareholder-information/share-repurchase-program
(http://www.indivior.com/en/investors/shareholder-information/share-repurchase-program)
.

 

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

 

Contact:

Jason Thompson

Vice President, Investor Relations

1-804-402-7123

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSDZGZMNNZGKZM